BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9448587)

  • 1. Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Kadono T; Tamaki K; Takehara K
    Br J Rheumatol; 1997 Dec; 36(12):1270-5. PubMed ID: 9448587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of circulating intercellular adhesion molecule-1 in patients with systemic sclerosis.
    Kiener H; Graninger W; Machold K; Aringer M; Graninger WB
    Clin Exp Rheumatol; 1994; 12(5):483-7. PubMed ID: 7842528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of class II major histocompatibility complex and intercellular adhesion molecule 1 expression on scleroderma fibroblasts and endothelial cells by interferon-gamma and tumor necrosis factor alpha in the early disease stage.
    Gruschwitz MS; Vieth G
    Arthritis Rheum; 1997 Mar; 40(3):540-50. PubMed ID: 9082943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro cytokine modulation of intercellular adhesion molecule-1 expression on systemic sclerosis dermal fibroblasts.
    Cho MM; Jimenez SA; Johnson BA; Harlow LA; Burrows JC; Koch AE
    Pathobiology; 1994; 62(2):73-81. PubMed ID: 7945915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased production of nitric oxide stimulated by interleukin-1beta in peripheral blood mononuclear cells in patients with systemic sclerosis.
    Yamamoto T; Sawada Y; Katayama I; Nishioka K
    Br J Rheumatol; 1998 Oct; 37(10):1123-5. PubMed ID: 9825753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supernatants from culture of type I collagen-stimulated PBMC from patients with cutaneous systemic sclerosis versus localized scleroderma demonstrate suppression of MMP-1 by fibroblasts.
    Brown M; Postlethwaite AE; Myers LK; Hasty KA
    Clin Rheumatol; 2012 Jun; 31(6):973-81. PubMed ID: 22367096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
    Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
    Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms].
    Zhu HL; DU Q; Chen WL; Zuo XX; Li QZ; Liu SJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):716-722. PubMed ID: 31420628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of circulating intercellular adhesion molecule-3 (cICAM-3) in Psoriasis.
    Griffiths CE; Boffa MJ; Gallatin WM; Martin S
    Acta Derm Venereol; 1996 Jan; 76(1):2-5. PubMed ID: 8721479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis.
    Cush JJ; Rothlein R; Lindsley HB; Mainolfi EA; Lipsky PE
    Arthritis Rheum; 1993 Aug; 36(8):1098-102. PubMed ID: 8102057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and shedding of intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 by normal and scleroderma fibroblasts. Effects of interferon-gamma, tumor necrosis factor alpha, and estrogen.
    Shi-Wen X; Panesar M; Vancheeswaran R; Mason J; Haskard D; Black C; Olsen I; Abraham D
    Arthritis Rheum; 1994 Nov; 37(11):1689-97. PubMed ID: 7526872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine production and serum levels in systemic sclerosis.
    Kantor TV; Friberg D; Medsger TA; Buckingham RB; Whiteside TL
    Clin Immunol Immunopathol; 1992 Dec; 65(3):278-85. PubMed ID: 1451330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis.
    Nakamura K; Asano Y; Taniguchi T; Minatsuki S; Inaba T; Maki H; Hatano M; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    J Dermatol; 2016 Aug; 43(8):912-8. PubMed ID: 26777734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated matrix metalloproteinase-9 in patients with systemic sclerosis.
    Kim WU; Min SY; Cho ML; Hong KH; Shin YJ; Park SH; Cho CS
    Arthritis Res Ther; 2005; 7(1):R71-9. PubMed ID: 15642145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement.
    Scala E; Pallotta S; Frezzolini A; Abeni D; Barbieri C; Sampogna F; De Pità O; Puddu P; Paganelli R; Russo G
    Clin Exp Immunol; 2004 Dec; 138(3):540-6. PubMed ID: 15544634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of vascular dysfunction markers reflect disease severity and stage in systemic sclerosis patients.
    Cossu M; Andracco R; Santaniello A; Marchini M; Severino A; Caronni M; Radstake T; Beretta L
    Rheumatology (Oxford); 2016 Jun; 55(6):1112-6. PubMed ID: 26989111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.
    Hasegawa M; Sato S; Takehara K
    Arch Dermatol Res; 2004 Jul; 296(2):89-93. PubMed ID: 15133694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis.
    Ichimura Y; Asano Y; Akamata K; Noda S; Taniguchi T; Takahashi T; Toyama T; Tada Y; Sugaya M; Sato S; Kadono T
    Arthritis Rheumatol; 2015 Dec; 67(12):3245-55. PubMed ID: 26245842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma.
    Ihn H; Fujimoto M; Sato S; Kikuchi K; Igarashi A; Soma Y; Takehara K
    J Am Acad Dermatol; 1994 Oct; 31(4):591-5. PubMed ID: 7916356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations.
    Dantas AT; Almeida AR; Sampaio MCPD; Cordeiro MF; Oliveira PSS; Mariz HA; Pereira MC; Rego MJBM; Pitta IDR; Duarte ALBP; Pitta MGDR
    Immunol Lett; 2018 Jun; 198():12-16. PubMed ID: 29601941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.